Real-life effectiveness evaluation of budesonide/formoterol (BF) Spiromax for the management of asthma and COPD

21/04/2016
29/03/2024
EU PAS number:
EUPAS13238
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

160301_R00615_Spiromax_Protocol_V3.0

English (1.22 MB - PDF) View document
Study results
Study results

170116_R00615_Spiromax_ph34_final_report_V1_3

English (4.41 MB - PDF) View document
Study report
Other information